Clinical Trials Sponsored by Galderma Canada

Total 4871 results

Innovaderm Research Inc.
Galderma Canada

Completed

Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion

Actinic Keratosis

Canada
Galderma R&D

Recruiting

A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

Psoriasis | Plaque Psoriasis

United States
Galderma R&D

Recruiting

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

Weight Loss | Skin Laxity | Photoaging | Photodamaged Skin | Volume Deficiency of the Midface

United States
Galderma R&D

Completed

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus (NemoCKDaP)

Chronic Kidney Disease Associated Moderate to Severe Pruritus

Spain, United States, Hungary, Poland
Galderma R&D

Completed

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Cheek Wrinkles | Midface Contour Deficiencies

Canada
Galderma R&D

Completed

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Glabellar Frown Lines | Canthal Lines

United States
Galderma R&D

Active, not recruiting

A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator With a Skincare Regimen

Photodamaged Skin | Volume Deficiency of the Midface

United States
Galderma R&D

Completed

Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers (RES)

Volume Deficiency of the Midface

United States
Galderma Laboratorium GmbH

Completed

ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis

Actinic Keratoses

Germany
Galderma R&D

Completed

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

Dermatitis, Atopic

United States
Galderma R&D

Completed

AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation (LEAP)

Acne Vulgaris

United States, Spain
Galderma R&D

Completed

A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area

Wrinkle

United States
Galderma R&D

Active, not recruiting

Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

Jawline Definition

Canada
Galderma R&D

Active, not recruiting

Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

Temporal Hollowing

United States
Galderma R&D

Completed

An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis

Prurigo Nodularis

United States, Germany, Austria, Canada, Denmark, Hungary, Italy, Poland, Sweden, United Kingdom
Galderma R&D

Completed

Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite

Cellulite

Canada
Galderma R&D

Active, not recruiting

Study to Evaluate the Safety and Effectiveness of GP0116 (NLF)

Skin Manifestations

United States
Galderma R&D

Active, not recruiting

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States
Galderma R&D

Completed

Restylane Defyne in a Stepwise Treatment Approach

Lower Face Folds and Lines

United States, Brazil, Italy
Galderma R&D

Completed

Pan Facial Volume Restoration (EVE)

Volume Loss (Soft Tissue Ptosis or Atrophy )

Brazil
Galderma R&D

Completed

Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic Varnish (COOL)

Foot Dermatoses

Iceland
Galderma R&D

Completed

Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds.

Nasolabial Folds

United States
Galderma R&D

Completed

Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane

Atrophy

France
Galderma R&D

Completed

Study to Evaluate Solesta for Treatment of Fecal Incontinence

Fecal Incontinence

Italy, Spain, France, Canada, Finland, Germany, Norway
Galderma R&D

Completed

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Glabellar Frown Lines

United States
Galderma R&D

Completed

Study to Evaluate Efficacy, Safety and Injection Technique of Restylane Lip Volume and Restylane Lip Refresh

Injection Techniques

Sweden
Galderma R&D

Completed

New Dermal Filler for Lip Augmentation

Lip Augmentation

United States
Galderma R&D

Completed

Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population

Healthy Volunteers

Taiwan
Galderma R&D

Completed

Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation

Lip Augmentation and Correction of Perioral Rhytids

United States
Galderma R&D

Completed

An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine

Acne Scars

Belgium
Galderma R&D

Completed

Subject Satisfaction With AbobutulinumtoxinA Treatment (DREAM)

Glabellar Frown Lines

United States
Galderma R&D

Completed

Durolane Compared to Saline in Patients With Unilateral Knee Osteoarthritis

Unilateral Knee Osteoarthritis

United Kingdom
Galderma R&D

Completed

ORCA - Oracea® for Rosacea: A Community-based Assessment

Rosacea

United States
Galderma R&D

Completed

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Study to Evaluate Restylane Vital Light Using an Injector Device

Aesthetics

Germany
Galderma R&D

Completed

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Psoriasis

United States
Galderma R&D

Completed

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Plaque Psoriasis

United States
Galderma R&D

Completed

Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea

Papulopustular Rosacea

United States
Galderma R&D

Completed

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

Psoriasis

United States, Canada
Galderma R&D

Completed

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo

Rosacea

United States
Galderma R&D

Completed

Mirvaso in Use Study

Rosacea

United States
Galderma R&D

Completed

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep

Wrinkles | Nasolabial Folds

Canada
Galderma R&D

Completed

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Psoriasis

United States
Galderma R&D

Completed

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Acne Vulgaris

United States
Galderma R&D

Completed

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Plaque Psoriasis

United States
Galderma R&D

Completed

Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion

Skin Irritation

United States
Galderma R&D

Completed

A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV) (DUAL)

Acne Vulgaris

United States, Puerto Rico
Galderma R&D

Completed

Dose Range Study of CD5789 in Acne Vulgaris

Acne Vulgaris

United States

3

Subscribe